ISOQOL 33rd Annual Conference
18-21 October 2026
Prague, Czech Republic

Important Dates
Late November 2025:
Workshop and Symposium Abstract Submissions Open
26 January 2026:
Workshop and Symposium Abstract Submissions Due
Early March 2026:
Oral, Brief & Poster Presentation Abstract Submissions Open
3 April 2026:
Presenters notify their intent to present
(Workshops and Symposia)
6 April 2026:
Oral, Brief & Poster Presentation Abstract Submissions Due
Mid-May 2026:
Award Nominations Due
15 May 2026:
Scholarship Applications Due
6 July 2026:
Presenters notify their intent to present
(Oral/Oral Brief/Poster)
6 July 2026:
Early Bird Registration Deadline
10 August 2026:
Presenter Registration Deadline
All Presenters Must Be Registered
21 September 2026:
Advanced Registration Deadline
24 September 2026:
ISOQOL Hotel Room Block Closes
11 October 2026:
Online Registration Closes
Conference Theme
Evaluate, Educate, Regulate
The increasing interest in the use of quality-of-life assessments and patient reported outcomes highlights that the messaging and supporting evidence is having an impact. At the 2026 conference we look to explore how the field should continue to evolve to maximize the reach and methodological quality of work being undertaken in the field. Across selected core areas of evaluation, education, and regulation we aim to showcase key drivers and considerations for enhancing the breadth and scope of PRO activity.
Plenary Sessions
Evaluate
The 2025 conference will have provided an important platform for AI driven approaches in quality of life and PRO research. In this session, 2026, we aim to explore some of the classical/traditional approaches/ideas to measurement and analysis of PRO data that underpin the field.
Educate
Where do we go next to strengthen the focus and reach of education in patient reported outcomes in clinical practice and beyond? Covering a range of clinical contexts along with the patient/carer perspectives, this session will be designed to showcase examples of successful strategies and approaches to multi-stakeholder PRO education. Speakers may highlight novel methods to develop and deliver education and also consider how we might approach educating wider stakeholder groups (e.g. hospital/health care facility managers).
Regulate
With increasing emphasis on the value and importance of the patient’s voice in drug development, this session will present an overview of the most current guidance from international regulators and decision-makers. This will include historical development of methods and applications such as FDA PRO guidance’s (2005, 2009) to the development and publication of the Patient Focused Drug Development Methodological Series and include wider international guidance’s and perspectives from European and Asian regulators.
Cutting Edge Research
The Cutting Edge Research plenary session features some of the highest-ranked, innovative research from ISOQOL abstract submissions. In particular, these abstracts reflect research that truly “pushes the ISOQOL envelope” in providing new and different ways to look at quality of life.
Scientific Program Committee Co-Chairs

Elizabeth J. Gibbons, MSc
Evidera (Thermo Fischer Scientific PPD Development)
London, United Kingdom

Kate Absolom, PhD
University of Leeds
Leeds, United Kingdom

The International Society for Quality of Life Research (ISOQOL) is a global community of researchers, clinicians, health care professionals, industry professionals, consultants, and patient research partners advancing health related quality of life research (HRQL).
Together, we are creating a future in which patient perspective is integral to health research, care and policy.